The exoS, exoT, exoU and exoY Virulotypes of the Type 3 Secretion System in Multidrug Resistant Pseudomonas aeruginosa as a Death Risk Factor in Pediatric Patients
2024

Virulotypes of Pseudomonas aeruginosa and Their Impact on Pediatric Patient Mortality

Sample size: 336 publication 10 minutes Evidence: moderate

Author Information

Author(s): Nolasco-Romero Carolina G., Prado-Galbarro Francisco-Javier, Jimenez-Juarez Rodolfo Norberto, Gomez-Ramirez Uriel, Cancino-Díaz Juan Carlos, López-Marceliano Beatriz, Apodaca Magali Reyes, Aguayo-Romero Mónica Anahí, Rodea Gerardo E., Pichardo-Villalon Lilia, Parra-Ortega Israel, Santos Fortino Solórzano, Moreno-Galván Mónica, Velázquez-Guadarrama Norma, Anderson Deborah

Primary Institution: Hospital Infantil de México Federico Gómez

Hypothesis

The study aims to analyze the distribution of exo genes in Pseudomonas aeruginosa strains and their relationships with clinical variables and outcomes in pediatric patients.

Conclusion

The virulotypes V1 and V2 are associated with a higher risk of death in pediatric patients infected with multidrug-resistant Pseudomonas aeruginosa.

Supporting Evidence

  • Virulotype V1 was associated with a nearly four-fold increased risk of death compared to V3.
  • Virulotypes V2 and V1 were most related to pandrug resistance.
  • Clinical records of 100 patients showed that 15 died, with a higher mortality rate linked to specific virulotypes.
  • Statistical analysis indicated significant associations between virulotypes and clinical outcomes.

Takeaway

This study found that certain types of germs can make kids very sick and even lead to death, especially if they are resistant to many medicines.

Methodology

The study used multiplex polymerase chain reaction to analyze the presence of exo genes in Pseudomonas aeruginosa strains from pediatric patients.

Potential Biases

Potential bias due to the retrospective nature of the clinical data review.

Limitations

The study was conducted at a single pediatric center, which may limit the generalizability of the findings.

Participant Demographics

Pediatric patients with cystic fibrosis and bloodstream infections.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% CI: 1.264–20.733 for V1 vs V3

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/pathogens13121030

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication